Lanreotide · source year
1 selected, source-linked Lanreotide records carrying a 2017 source date. This is a navigational view of PeptideScanner’s selected coverage—not a complete research timeline or a statement about safety or effectiveness.
1 selected record.
1 represented type.
1 distinct public record.
Cited chronology
Clinical trials
PeptideScanner retained ClinicalTrials.gov record NCT02351128 at 2026-07-30T21:22:00.252Z. Its registry update date was 2017-10-18, and PeptideScanner's reviewed identity mapping was lanreotide.
Source: ClinicalTrials.gov ↗